Skip to content
Checked.be
Complete company report
Generated 03-08-2026
Active BE 0764.522.425Public limited company

Cellaïon

Rue Granbonpré 11 ·1435 Mont-Saint-Guibert, Belgium· 5 yrs active
Sector: Human health (86995)
Conclusion Checked

The computed 12-month bankruptcy probability of Cellaïon is 0.3% (very low). The 2024 annual accounts show negative equity (€-13.85M) and a net result of €-7.71M. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 256 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.
Key figures
Equity €-13.85M
Net result €-7.71M
Staff (FTE) 15.5
Better than sector 5%
Snowflake analysis 5 axes · computed by Checked
Health20Profitability100Solvency41Growth32Stability94
57 / 100

Mixed profile: strong on profitability, weaker on health.

Health 20
Profitability 100
Solvency 41
Growth 32
Stability 94
Bankruptcy probability (12 mo) Checked model v1 · free
0.3% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector −Young company +Annual accounts: weaker financial profile +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 3 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags 0 events
No administrative flags
Health barometer FY 2024 · computed
20 / 100 Critical
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.
Financial overview4 NBB filings
Annual accounts filed on 18-07-2025 with the NBB · fiscal year 2024 · volledig
€-15.00M€-10.00M€-5.00M€0Operating result 2021: €-5.62M€-5.62MNet result 2021: €-5.64M€-5.64MOperating result 2022: €-9.24M€-9.24MNet result 2022: €-9.39M€-9.39MOperating result 2023: €-13.15M€-13.15MNet result 2023: €-13.23M€-13.23MOperating result 2024: €-7.69M€-7.69MNet result 2024: €-7.71M€-7.71M2021202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
volatile Too volatile to project: the yearly deviation from the trend is ~42% of the level (threshold 35%). We therefore deliberately show no projection line.
€-15.00M€-10.00M€-5.00M€02021: €-5.58M2022: €1.05M2023: €-6.14M2024: €-13.85M2021202220232024
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (full schema)
Metric This company Sector median Position in the sector
Solvency -592.9% 50.6%
better than 5% of 256 sector peers
Net result €-7.71M €50k
better than 5% of 255 sector peers
Equity €-13.85M €122k
better than 5% of 256 sector peers
Gross operating margin €-4.03M €144k
better than 5% of 251 sector peers
Staff costs €3.41M €156k
higher than 95% of 114 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
EBITDA
€-7.58M
+41.2% far below sector median
Net profit
€-7.71M
+41.8% far below sector median
Cash flow
€-7.60M
+41.4% far below sector median
Total assets
€2.34M
-68.8% +133% vs sector
Equity
€-13.85M
-125.5% far below sector median
Working capital
€-376k
- far below sector median
Employees (FTE)
16
-38.5% far above sector median
Staff costs
€3.41M
+12.5% far above sector median
Income taxes
€2k
-54.6% -79% vs sector
Debt
€15.10M
+30.7% far above sector median
Debt ≤ 1y
€2.50M
-18.5% far above sector median
Debt > 1y
€12.61M
+48.4% far above sector median
Current ratio
0.85
-59.4% -71% vs sector
Quick ratio
0.85
-55.6% -71% vs sector
Solvency
-592.9%
-622.8% far below sector median
Debt / equity
-1.09
+42.0% far below sector median
ROE
55.7%
-74.2% far above sector median
ROA
-330.1%
-86.7% far below sector median
Interest coverage
-105.13
-35.3% far below sector median
Figures by fiscal year
Fiscal year2024
Revenue-
EBITDA€-7.58M
Net profit€-7.71M
Cash flow€-7.60M
Staff costs€3.41M
Income taxes€2k
Dividends-
Total assets€2.34M
Equity€-13.85M
Debt€15.10M
of which ≤ 1y€2.50M
of which > 1y€12.61M
Working capital€-376k
Employees (FTE)15.5
Ratios (computed)
2024
Current ratio0.85
Quick ratio0.85
Working capital ratio-16.1%
Solvency-592.9%
Debt / equity-1.09
Long-term debt ratio-0.91
Interest coverage-105.13
Gross margin-
Net margin-
ROA-330.1%
ROE55.7%
EBITDA margin-
Days sales outstanding-
Days payable outstanding174d
Inventory turnover-
Days inventory (DSI)0d
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€2.34M
Fixed assets 21/28€214k
Formation expenses 20€0
Intangible fixed assets 21€0
Tangible fixed assets 22/27€0
Financial fixed assets 28€214k
Current assets 29/58€2.12M
Stocks & contracts in progress 3€0
Amounts receivable within one year 40/41€869k
Cash & bank 54/58€1.25M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€2.34M
Equity 10/15€-13.85M
Contributions / capital 10/11€7.09M
Accumulated profits (losses) 14€-20.94M
Provisions & deferred taxes 16€1.08M
Amounts payable 17/49€15.10M
Amounts payable after one year 17€12.61M
Amounts payable within one year 42/48€2.50M
Trade debts payable within one year 44€2.49M
Income statement
Gross operating margin 9900€-4.03M
Operating result 9901€-7.69M
Financial income 75€53k
Financial charges 65€72k
Result before taxes 9903€-7.71M
Income taxes 67/77€2k
Net result for the period 9904€-7.71M
Result to be appropriated 9905€-7.71M
You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.
Legal Structure
NACE primary Human health(86995)
Legal form Public limited company(014)
Incorporation02-03-2021
StatusActive
Postal code1435
Establishment units 1 location
-
Rue Granbonpré 11, 1435 Mont-Saint-GuibertSpeur- en ontwikkelingswerk op biotechnologisch gebied
since 20212.317.528.750
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
25020B0074/00B002 Wallonia 6.2 ha 1 · 17 m² 7.8 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 9 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2025
18-07-2025
NBB filing Annual accounts filed
fiscal year 2024 · volledig
2024
15-07-2024
State Gazette act End of life
Kim LAGAE
27-06-2024
NBB filing Annual accounts filed
fiscal year 2023 · volledig
2023
23-06-2023
State Gazette act Capital & shares
Kim Lagae
09-06-2023
NBB filing Annual accounts filed
fiscal year 2022 · volledig
02-02-2023
State Gazette act Capital & shares
Kim LAGAE
2022
24-06-2022
NBB filing Annual accounts filed
fiscal year 2021 · volledig
09-02-2022
State Gazette act Capital & shares
Kim Lagae
26-01-2022
State Gazette act Capital & shares
Kim Lagae
Belgisch Staatsblad, acts 5 acts
Capital history · 4
23-06-2023
Capital change
02-02-2023
Capital change
09-02-2022
Capital change
26-01-2022
Capital change
All acts · 5 updated 2 years ago
2024
15-07-2024 Dissolution with immediate closure of the liquidation End of life·Kim LAGAE
  • Ontbinding: 2024-06-03
Notary: Kim LAGAE · Bruxelles
Technical details 
{
  "notary": {
    "name": "Kim LAGAE",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "auditor": null,
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-07-15",
    "filing_date": null,
    "act_kind_objet": "DISSOLUTION DE LA SOCIETE - NOMINATION D\u0027UN LIQUIDATEUR-"
  },
  "decision": {
    "body": "assembl\u00E9e_g\u00E9n\u00E9rale_extraordinaire",
    "act_date": "2024-06-03",
    "unanimous": null
  },
  "end_event": {
    "reason": "Dissolution par assembl\u00E9e g\u00E9n\u00E9rale",
    "art_wvv": [
      "2:88"
    ],
    "sub_type": "voluntary_dissolution_with_close",
    "closure_effective_date": null,
    "dissolution_effective_date": "2024-06-03",
    "closure_effective_date_is_approximate": false,
    "dissolution_effective_date_is_approximate": false
  },
  "liquidator": {
    "kind": "org",
    "org_kbo": "0432.711.951",
    "org_name": "Janson",
    "person_dob": null,
    "person_rrn": null,
    "is_judicial": false,
    "person_name": null,
    "is_remunerated": true,
    "person_address": null,
    "person_birth_place": null
  },
  "silent_merger": null,
  "court_division": {
    "name": "TRIBUNAL BE L\u0027ENTREPRISE DU BRABANT WALLON",
    "language": "fr",
    "tribunal_type": "entreprise"
  },
  "books_custodian": null,
  "subject_company": {
    "kbo": "0764.522.425",
    "name_full": "Cella\u00EFon",
    "legal_form": "SA"
  },
  "closure_mandatary": null,
  "prior_opening_ref": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Kim Lagae",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "une exp\u00E9dition conforme de l\u0027acte",
    "des procurations",
    "le rapport sp\u00E9cial \u00E9tabli par le conseil d\u0027administration conform\u00E9ment \u00E0 l\u0027article 2:71 \u00A72 du Code des soci\u00E9t\u00E9s et des associations",
    "le rapport sp\u00E9cial \u00E9tabli par le commissaire conform\u00E9ment \u00E0 l\u0027article 2:71 \u00A72 du Code des soci\u00E9t\u00E9s et des associations"
  ],
  "real_estate_transferred": [],
  "shareholder_loan_settled": null,
  "financials_at_dissolution": null,
  "distribution_to_shareholders": null
}
2023
23-06-2023 Capital increase of €5,533,714 to €21,620,314.02 Capital & shares·Kim Lagae
  • €16.086.600,02 → €21.620.314,02
  • Inbreng in geld · Apport en numéraire
Notary: Kim Lagae · Bruxelles
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 21620314.02,
      "delta_eur": 5533714.0,
      "before_eur": 16086600.02,
      "share_emission": {
        "agio_eur": null,
        "share_form": "nominal",
        "share_class": "B",
        "n_new_shares": 55336,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 100.0
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 5533714.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Kim Lagae",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-06-23",
    "filing_date": "2023-06-21",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2023-06-13",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0764.522.425",
    "name_full": "Cella\u00EFon",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition",
    "rapport sp\u00E9cial du conseil d\u0027administration",
    "rapport du commissaire",
    "coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 256309,
      "class_name": "B",
      "capital_share_eur": 21620314.02,
      "voting_rights_per_share": null
    }
  ]
}
02-02-2023 Capital increase of €8,000,100 to €16,086,600.01 Capital & shares·Kim LAGAE
  • €8.086.500,01 → €16.086.600,01
Notary: Kim LAGAE · Bruxelles
Technical details 
{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 16086600.01,
      "delta_eur": 8000100.0,
      "before_eur": 8086500.01,
      "share_emission": {
        "agio_eur": 800010.01,
        "share_form": "nominal",
        "share_class": "B",
        "n_new_shares": 80001,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 0.01
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 8000100.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": 80001,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "statutory_reserve_release",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": "reserves_incorporation",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_distributable"
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Kim LAGAE",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-02-02",
    "filing_date": "2023-01-31",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2022-12-29",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0764.522.425",
    "name_full": "Cella\u00EFon",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "procurations",
    "Rapport sp\u00E9cial du conseil d\u0027administration",
    "Rapports du commissaire",
    "coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": null,
      "class_name": "Ordinaires",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": null,
      "class_name": "Ordinaires sans droit de vote",
      "capital_share_eur": null,
      "voting_rights_per_share": 0.0
    },
    {
      "n_shares": null,
      "class_name": "Classe B",
      "capital_share_eur": null,
      "voting_rights_per_share": 2.0
    }
  ]
}
2022
09-02-2022 Transaction in capital or shares Capital & shares·Kim Lagae
Notary: Kim Lagae · Bruxelles
Technical details 
{
  "events": [],
  "notary": {
    "name": "Kim Lagae",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": null,
    "filing_date": "2022-01-28",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "notarieel_alleen",
    "act_date": "2022-01-17",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0764.522.425",
    "name_full": "PROMETHERA BIOSCIENCES Thuofeutico",
    "legal_form": "soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Kim Lagae",
    "org_rep_person_name": null,
    "person_role_at_subject": "notaire instrumentant"
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u0027acte"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}
26-01-2022 Capital increase Capital & shares·Kim Lagae
  • 2 kapitaalbewegingen in deze akte
Notary: Kim Lagae · Bruxelles
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 5371749.98,
      "delta_eur": 5210249.98,
      "before_eur": 61500.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 52102,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 5210249.98,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "_arith_inconsistent": true,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 8086500.0,
      "delta_eur": 2814750.02,
      "before_eur": 5371749.98,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 28648,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 100.0
      },
      "decrease_purpose": null,
      "contribution_type": "natura",
      "paid_up_delta_eur": 2814750.02,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "_arith_inconsistent": true,
      "merger_new_shares_n": 28648,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "actions_ordinaires_sans_droit_de_vote",
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_conversion",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": 1.0,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "Abda Lilly SRL",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "A Q Invest SRL",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "actions_ordinaires_sans_droit_de_vote",
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_conversion",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": 1.0,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Kim Lagae",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-01-26",
    "filing_date": "2022-01-24",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2022-01-17",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2022-01-17"
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": null,
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": null
  },
  "subject_company": {
    "kbo": "0764.522.425",
    "name_full": "Promethera Therapeutics",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal avec annexes",
    "procurations",
    "rapport sp\u00E9cial du conseil d\u0027administration",
    "rapports du commissaire",
    "coordination des statuts"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "Abda Lilly SRL",
      "role": null,
      "n_shares": null,
      "share_class": null
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "A Q Invest SRL",
      "role": null,
      "n_shares": null,
      "share_class": null
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 107534,
      "class_name": "actions_ordinaires",
      "capital_share_eur": 8086500.01,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 26669,
      "class_name": "actions_ordinaires_sans_droit_de_vote",
      "capital_share_eur": 0.01,
      "voting_rights_per_share": 0.0
    }
  ]
}
Credit advice verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.
Company registry (CBE) Crossroads Bank
Activities
Overige menselijke gezondheidszorg, n.e.g.86909Activiteiten op het gebied van voeding86995Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110
Primary activity highlighted.
Names & trade names
Legal nameFR Cellaïon
Registered office
Rue Granbonpré 11
1435 Mont-Saint-Guibert, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same NACE
Experconsult BE 0454.735.010 · Brussel
Evara BE 0406.633.304 · Gent
ADMINE BE 0473.863.410 · Walhain
AGENCE EUROPEENNE POUR LE DEVELOPPEMENT ET LA SANTE BE 0450.913.705 · Brussel
ALBEDOS BE 0506.688.309 · Braine-l'Alleud
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative